1. Home
  2. ACGL vs NTRA Comparison

ACGL vs NTRA Comparison

Compare ACGL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arch Capital Group Ltd.

ACGL

Arch Capital Group Ltd.

HOLD

Current Price

$93.40

Market Cap

34.0B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$181.80

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACGL
NTRA
Founded
2001
2003
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
28.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ACGL
NTRA
Price
$93.40
$181.80
Analyst Decision
Buy
Strong Buy
Analyst Count
15
14
Target Price
$108.79
$259.07
AVG Volume (30 Days)
1.4M
1.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
N/A
$18.16
Revenue Next Year
$3.72
$20.00
P/E Ratio
$8.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$82.45
$125.38
52 Week High
$102.90
$256.36

Technical Indicators

Market Signals
Indicator
ACGL
NTRA
Relative Strength Index (RSI) 41.72 34.86
Support Level $90.62 $157.43
Resistance Level $94.33 $181.85
Average True Range (ATR) 1.48 7.08
MACD -0.07 -0.15
Stochastic Oscillator 38.96 1.62

Price Performance

Historical Comparison
ACGL
NTRA

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: